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Abstract
Background: Pneumonia is among the main causes of illness and death in children <5 years of age. There is a
need to better describe the epidemiology of viral community-acquired pneumonia (CAP) in developing countries.
Methods: From July 2004 to June 2007, we examined nasopharyngeal aspirates (NPA) from 2,230 cases of
pneumonia (World Health Organization criteria) in children 2 to 35 months old recruited in a randomized trial
of zinc supplementation at a field clinic in Bhaktapur, Nepal. The specimens were examined for respiratory
syncytial virus (RSV), influenza virus type A (InfA) and B (InfB), parainfluenza virus types 1, 2 and 3 (PIV1, PIV2,
and PIV3), and human metapneumovirus (hMPV) using a multiplex reverse transcriptase polymerase chain
reaction (PCR) assay.
Results: We identified 919 virus isolates in 887 (40.0%) of the 2,219 NPA specimens with a valid PCR result, of
which 334 (15.1%) yielded RSV, 164 (7.4%) InfA, 129 (5.8%) PIV3, 98 (4.4%) PIV1, 93 (4.2%) hMPV, 84 (3.8%) InfB,
and 17 (0.8%) PIV2. CAP occurred in an epidemic pattern with substantial temporal variation during the three
years of study. The largest peaks of pneumonia occurrence coincided with peaks of RSV infection, which occurred
in epidemics during the rainy season and in winter. The monthly number of RSV infections was positively
correlated with relative humidity (rs = 0.40, P = 0.01), but not with temperature or rainfall. An hMPV epidemic
occurred during one of the three winter seasons and the monthly number of hMPV cases was also associated with
relative humidity (rs = 0.55, P = 0.0005).
Conclusion: Respiratory RNA viruses were detected from NPA in 40% of CAP cases in our study. The most
commonly isolated viruses were RSV, InfA, and PIV3. RSV infections contributed substantially to the observed
CAP epidemics. The occurrence of viral CAP in this community seemed to reflect more or less overlapping
micro-epidemics with several respiratory viruses, highlighting the challenges of developing and implementing
effective public health control measures.
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Background
Viruses are important causes of lower respiratory tract
infection (LRTI) in developing countries [1-3]. The most
common cause of viral LRTI is RNA viruses: respiratory
syncytial virus (RSV), human parainfluenza virus (PIV),
influenza virus, and human metapneumovirus (hMPV).
Adenovirus is probably the only DNA virus that is a com-
mon cause of LRTI in children [2].
Respiratory viruses, and especially RSV, are leading causes
of hospitalization in infants and young children during
the cold season in temperate climates [4,5]. Studies in the
1980s highlighted the importance of viruses in LRTI and
identified RSV as the predominant cause in children aged
<5 years also in developing countries [6]. This was con-
firmed in a WHO-sponsored denominator-based study of
RSV-associated LRTI in four developing countries [7].
Moreover, while influenza virus is being recognized as
causing severe LRTI in otherwise healthy children in high-
income countries [8], little information on its epidemiol-
ogy is available from resource-poor settings. A few studies
on the more recently discovered hMPV have been pub-
lished, but these studies were small and covered varying
seasons and age groups [9-11]. Seasonality of RSV and
influenza in tropical and sub-tropical regions differs from
the well-defined seasonal outbreaks seen in temperate cli-
mates, and the seasonal pattern of these infections in
developing countries varies considerably between regions
[1,12]. Knowledge of the local epidemiology of these
infections is essential for predicting epidemics and plan-
ning preventive measures, such as development and intro-
duction of vaccines in low- and middle-income countries.
Polymerase chain reaction (PCR) is a novel, but now
widely applied, method for the detection of respiratory
viruses from clinical samples. Compared with conven-
tional methods, PCR has significantly increased sensitivity
for respiratory viral diagnosis [13,14] and has also dem-
onstrated high specificity [15,16]. Viral etiology data for
community-acquired pneumonia (CAP) from developing
countries based on molecular diagnostic methods are
scarce, however, and no such studies have to our knowl-
edge been conducted over several years and on a large
number of children.
We sought to identify common viral pathogens in CAP in
a large number of Nepalese children 2 to 35 months of age
visiting a field clinic. We also wished to describe the sea-
sonal pattern of respiratory viral infections over a 3-year
period and explore possible associations with available
meteorological data.
Methods
Study area
Study participants were recruited from the district of
Bhaktapur in the Kathmandu Valley, Nepal. A total of
1,913 (86.2%) of the 2,219 cases were recruited from
within Bhaktapur municipality, a semi-urban agricultural
based town with a population of approximately 80,000,
of which we at any time had approximately 4,500 chil-
dren 2 to 35 months of age under surveillance for respira-
tory illness. Low income, low dietary intakes and low
consumption of dairy and animal products are wide-
spread, as in most parts of Nepal. Malnutrition, mainly
manifested as stunting and anemia, are common among
children less than 5 years of age [17].
The Kathmandu Valley is situated at an altitude of 1,300
to 1,350 meters above sea level and has a sub-tropical,
temperate climate. There are four distinct seasons; pre-
monsoon/spring (March to May), monsoon/summer
(June to September), post-monsoon/autumn (October to
November) and winter (December to February) [18].
Temperatures may rise to 35°C in summer, while mini-
mum temperatures can fall to 0°C in winter.
Study subjects and case definition
We recruited cases from an open cohort of children less
than 3 years of age, who were under monthly active and
passive surveillance for respiratory illness. Trained field-
workers referred children with respiratory complaints to
the study clinic at the outpatient department (OPD) at
Siddhi Memorial Hospital in Bhaktapur, and families
could bring their children for free treatment at our clinic
for common childhood illnesses. Children residing in
Bhaktapur district, but outside the municipality, were
only under such passive surveillance. Children aged 2 to
35 months presenting at our study clinic were screened for
fast breathing or lower chest wall indrawing (LCI) and
classified according to the standard World Health Organ-
ization (WHO) algorithm for acute respiratory infection
(ARI) [19] (Figure 1). Pneumonia was defined as cough or
difficult breathing combined with fast breathing, that is ≥
50 breaths/min for children 2 to 11 months old, and ≥ 40
breaths/min for children ≥ 12 months old. Severe pneu-
monia was defined as cough or difficult breathing com-
bined with LCI. Children with audible or auscultatory
wheeze were given 2 doses of 2.5 mg nebulized salbuta-
mol administered 15 min apart followed by reassessment
after 30 min, which is in accordance with the revised
WHO guidelines [20]. A child was included only if he or
she had fast breathing or LCI at reassessment.
During a 3-year period from 29 June 2004 to 30 June
2007, we collected 2,230 nasopharyngeal aspirate (NPA)
specimens from equally many cases of pneumonia in
1,909 children (some children were included more than
once). These children were, after obtaining informed
parental consent, included in a study on zinc as adjuvant
therapy for CAP (to be presented elsewhere). All included
children were randomized to receive either 10 to 20 mg
elemental zinc dispersed in water or placebo tablets dailyBMC Medicine 2009, 7:35 http://www.biomedcentral.com/1741-7015/7/35
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for 14 days. Cases with very severe pneumonia/disease,
that is, cough or difficult breathing with stridor when
calm or any general danger signs (inability to drink/
breastfeed, persistent vomiting, convulsions, lethargy, or
unconsciousness) were not included in the study, but
instead referred to a tertiary level hospital after initial
treatment. Other exclusion criteria are listed in the study
profile (Figure 1). Children could not participate in the
study again until after 6 months due to the 6-month fol-
low-up scheme of the clinical trial.
Field procedures
The child's respiratory rate (RR) was assessed according to
WHO guidelines [19], counting twice for 1 min using a
UNICEF timer. The lower of the two counts was used in
the analyses. Children were weighed using a UNICEF elec-
tronic scale (SECA, Hamburg, Germany) accurate to 100 g
with a mother/child-function, so the weight of the child
could be determined while held by his or her mother. The
child's length/height was measured to the nearest 0.1 cm
using a wooden measuring board (as recumbent length in
children <2 years of age and as height in children ≥ 2 years
of age). Oxygen saturation (SpO2) was measured either on
a finger or a toe with a pulse oxymeter (Siemens MicO2,
Siemens Medical Systems Inc, Danvers, MA, USA) using a
pediatric sensor (Nellcor, Pleasanton, CA, USA). It was
recorded twice 1 min apart after stabilization of the sensor
for 1 min. The higher of the two measurements was used
in the analyses. The concentration of C-reactive protein
(CRP) was determined from a capillary or venous blood
specimen using a semi-quantitative rapid test (QuikRead®
CRP, Orion Diagnostica, Espoo, Finland) and a portable
photometer (QuikRead® 101, Orion Diagnostica) accord-
ing to the manufacturer's instruction. The test had a meas-
urement range of 8 to 160 mg/L and values outside the
measurement range were indicated as <8 or >160 mg/L.
NPA specimens were obtained using a sterile, disposable
suction catheter (Pennine Healthcare Ltd, Derbyshire,
Study profile for children 2 to 35 months of age included in a study of viral community-acquired pneumonia in Bhaktapur,  Nepal, from July 2004 to June 2007 Figure 1
Study profile for children 2 to 35 months of age included in a study of viral community-acquired pneumonia in 
Bhaktapur, Nepal, from July 2004 to June 2007. Severe malnutrition was defined as <70% NCHS (National Center for 
Health Statistics) median weight for height. Severe anemia was defined as hemoglobin <7 g/dl.
2,088
non-severe
pneumonia
131
severe
pneumonia
7,383 patients with cough 
or difficult breathing 
screened
2,761 pneumonia 
according to WHO criteria
2,258 included for NPA 
collection
4,622 no pneumonia 
according to WHO criteria
503 meeting exclusion criteria 
Previously included <6 months ago: 8 
Very severe pneumonia: 2 
Other severe illness: 21 
Documented tuberculosis: 2 
Antibiotics last 48 hours: 236 
Dysentery: 7 
Severe malnutrition: 3 
Congenital heart disease: 9 
Severe anemia: 2 
Cough >14 days: 3 
No consent: 210 
Not able to obtain NPA: 28 
Invalid PCR result: 11 BMC Medicine 2009, 7:35 http://www.biomedcentral.com/1741-7015/7/35
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UK) with a suction trap (trachea suction set, Unomedical
a/s, Birkerød, Denmark) connected to a foot pump
(Ambu® Uni-Suction Pump, Ambu A/S, Ballerup, Den-
mark). The catheter was inserted through the nostril to a
distance equivalent to that between the patient's earlobe
and nostril [21]. Suction was applied for a minimum of
10 sec with maximum negative pressure of 200 mmHg.
Secretion remaining in the catheter after suction was
recovered by rinsing 2 to 3 ml virus transport medium
(DiagnoStick®, Department of Microbiology, University
Hospital of North Norway, Tromsø, Norway or UTM,
Copan Diagnostics Inc, Corona, CA, USA) through the
catheter into the suction trap. The trap was then discon-
nected and sealed.
Storage of nasopharyngeal aspirates
The specimens were refrigerated at 2 to 8°C following col-
lection at the field clinic and transported on ice every
working day to the main laboratory in Kathmandu, where
they were vortexed and divided into three equal aliquots
in sterile vials (CryoTubes™, Nunc AS, Roskilde, Den-
mark). The aliquots analyzed in Nepal were either frozen
at -70°C or kept at 2 to 8°C in the refrigerator before anal-
ysis. A separate comparative study verified that there were
no substantial differences in proportion detected between
the two alternative storage temperatures for up to three
months (unpublished data). One aliquot was immedi-
ately frozen at -70°C and transported to Norway on dry
ice and again stored at -70°C in case there should be a
need for reanalysis.
Identification of respiratory RNA viruses
One aliquot of each specimen was tested at our research
laboratory in Nepal at the Institute of Medicine, Tribhu-
van University, for RSV, InfA and InfB, PIV types 1, 2 and
3, and hMPV using a commercially available multiplex
reverse transcriptase PCR assay (Hexaplex Plus®, Prodesse
Inc, Waukeshaw, WI, USA) with minor modifications of
the manufacturer's instructions [22] and according to pre-
vious descriptions [15]. In brief, nucleic acids were
extracted from 360 μl of NPA (or plasmid RNA from pos-
itive control transcripts) using a nucleic acids extraction
kit (Roche High Pure Viral Nucleic Acid Kit, F. Hoffman-
La Roche Ltd, Basel, Switzerland) according to the manu-
facturer's instructions. Each run of the assay included a
positive RNA control and a negative control (virus trans-
port medium), starting at nucleic acid isolation. Speci-
mens and negative controls were individually spiked with
40 μl of internal control during nucleic acid isolation to
identify any inhibitors. cDNA was produced by reverse
transcription using random hexamers, murine leukemia
virus reverse transcriptase (ABI, Applied Biosystems, Fos-
ter City, CA, USA), RNase inhibitor (ABI) and 3 μl of
extracted viral RNA. Amplification reactions were per-
formed using GeneAmp® PCR System 2700 (ABI). Ten μl
of newly synthesized cDNA was added to a mix consisting
of 2.5 U of AmpliTaq® Gold DNA polymerase (ABI) and a
Super-Mix containing seven pairs of forward and back-
ward primers flanking unique sequences of the seven
viruses (the hemagglutinin neuraminidase gene of PIV
types 1, 2 and 3, the matrix protein gene of InfA, the NS1
and NS2 genes of InfB, the NS1 and NS2 genes of RSV and
the nucleocapsid gene of hMPV). After initially holding
the PCR mixture at 95°C for 10 min, amplification was
performed as follows: two cycles at 95°C for 1 min, 55°C
for 30 sec and 72°C for 45 sec, and then 38 cycles at 94°C
for 1 min, 60°C for 30 sec, 72°C for 30 sec, followed by
an additional 7 min at 72°C and immediate cooling to
4°C. After amplification, the PCR products were purified
using Qiagen QIAquick PCR Purification Kit (QIAGEN
Inc, Valencia, CA, USA) and analyzed by enzyme hybridi-
zation assay [15], measuring the optical density at 450 nm
(OD450) using a micro-plate reader (Stat Fax®  2100,
Awareness Technology Inc, Palm City, FL, USA).
Three hundred and twenty-four NPA aliquots were stored
beyond 3 months at 2 to 8°C before analysis in Nepal. Of
these, we re-analyzed the 133 that yielded a negative
result, now using the aliquot that had been frozen at -
70°C and transported on dry ice to Norway. This was
done at the Department of Microbiology and Infection
Control, University Hospital of North Norway, Tromsø,
Norway, using the Hexaplex Plus assay and an automated
extraction platform (NucliSens®  easyMAG, bioMérieux,
Durham, NC, USA). Nucleic acids were extracted from
400 μl of sample, negative and positive processing con-
trols and amplification control using the extraction prin-
ciple with magnetic particles of this platform.
Definitions of cut-off values and interpretation of PCR 
results
The criteria for a positive test were OD450 ≥ 0.400 and at
least four times greater than the OD450 of the negative con-
trol [22]. An OD450 < 0.300 with an OD450 of the internal
control >2.00 indicated a negative test. A reading from
0.300 to 0.399 was interpreted as indeterminate and the
sample examined again. If the same result was obtained
on repeated testing, the NPA was deemed negative. If the
OD450 of the internal control for a given NPA was <2.00
and sample absorbance was < 0.400 for all tested agents,
the NPA was tested again. If the same result was obtained
on repeated testing, the interpretation was indeterminate
due to potential inhibition, and the case not included in
the analyses.
Data management and statistical analyses
The data were double entered and compared on a daily
basis using Microsoft Visual FoxPro version 6.0 (Microsoft
Corporation, Redmond, WA, USA). Statistical analyses
were performed using Stata/MP 10.0 for Macintosh (StataBMC Medicine 2009, 7:35 http://www.biomedcentral.com/1741-7015/7/35
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Corporation, College Station, TX, USA). The 95% confi-
dence intervals (CI) for proportions were calculated with
binominal exact confidence interval using the 'ci' com-
mand. Of the children included in this analysis, 274 were
enrolled twice and 18 thrice. We used the 'cluster' option
in Stata to adjust the confidence intervals of the propor-
tions for repeated enrollments and thus allowed for pos-
sible dependence of observations in a child that was
included more than once. Anthropometric measures were
expressed as Z-scores, which were generated using the
WHO Child Growth Standards 2005 [23]. Meteorological
data for the Kathmandu airport weather station (located
approximately 10 km from Bhaktapur) were obtained
from Department of Hydrology and Meteorology, Minis-
try of Environment, Science and Technology, Kathmandu,
Nepal. Mean daily values for relative humidity and tem-
perature were calculated as the average of two daily meas-
urements (relative humidity at 8.45 AM and 5.45 PM, and
maximum and minimum temperature). We estimated the
Spearman rank order correlation coefficient to describe
the association between the monthly number of infec-
tions with each virus and meteorological factors.
Ethical considerations
The study had ethical clearance from the Research Ethics
Committee of the Institute of Medicine at Tribhuvan Uni-
versity in Kathmandu and the Regional Committee for
Medical and Health Research Ethics of Western Norway.
The implementation of the project was in agreement with
the international ethical principles for medical research
involving human subjects as stated in the latest version of
the Helsinki Declaration.
Results
We excluded 11 cases from the analysis due to inhibition
of the PCR. Out of the remaining 2,219 pneumonia cases,
1,263 (56.9%) were boys and 1,016 (45.8%) were infants
(<1 year). The mean (SD) age was 13.4 (8.3) months
(median 12, inter-quartile range (IQR) 6 to 19) (Table 1).
A total of 887 cases (40.0%) tested positive for one or
more viruses (CI 37.9%, 42.0%). We identified 919 iso-
lates in NPA from these 887 cases. RSV was the most com-
monly identified virus with 334 cases out of 887 (37.7%),
corresponding to 15.1% of all pneumonia cases (Table 2).
Influenza A was detected in 7.4% of all cases and hence
was the second most common virus isolated. Severe pneu-
monia was diagnosed in 131 (5.9%) children and 36
(27.5%) of these had RSV infection. The proportion of
samples that was positive for at least one of the seven
viruses varied from month to month, ranging from 2.3%
to 84.5%.
Infection with more than one virus was identified in 29
(3.3%) of the 887 positive specimens. The most common
double infection was PIV3 in combination with hMPV,
which was found in nine cases. We identified three viruses
in one case (PIV1, PIV2, RSV) and four viruses in another
(PIV1, PIV2, InfB, RSV).
The occurrence of CAP during the course of our study
exhibited substantial temporal variation and a clear epi-
demic pattern (Figure 2). In each of the three years, we
observed a sharp increase in the occurrence of pneumonia
at the end of the monsoon season in August to September.
There were also significant CAP epidemics during winter,
the first year peaking in February and the second year in
December, but we observed no winter epidemic in the
third year. There were also smaller peaks of CAP in spring.
Epidemics of infection with individual respiratory viruses
contributed to literally all of these CAP epidemics, such as
the three RSV epidemics (the second of which was com-
pounded by epidemics with InfA and InfB infections), an
InfA epidemic superimposed on an hMPV epidemic, and
a PIV3 epidemic (Figure 3). Displays of the spatial-tempo-
ral distribution of these individual epidemics are visual-
ized in [24]. PIV1 infections occurred in small numbers
throughout the year, whereas only 17 cases of PIV2 infec-
tion were seen during the entire study period.
The monthly distribution of RSV infections and meteoro-
logical data are shown in Figure 4. The monthly number
of RSV infections was positively correlated with relative
humidity in the Spearman's correlation analysis, but not
with temperature or rainfall (Table 3). The same associa-
tion with relative humidity was seen for hMPV. In con-
trast, the number of PIV3 was positively associated with
both temperature and rainfall, and not with relative
humidity. InfA did not correlate with any of these meteor-
ological factors, while InfB showed moderate negative
correlation with all three factors.
Discussion
This is to our knowledge the largest epidemiological study
in almost four decades of childhood CAP in a developing
country that identifies several common viruses. We iso-
lated at least one viral pathogen using PCR from 40% of
children during the 3-year study period. The literature
reveals few studies based on sensitive molecular diagnosis
from similar resource-poor settings. Apart from recent
studies on hMPV, most previous studies in developing
countries have not used PCR for virus detection [1].
Hospital-based studies in children <5 years of age from
developing countries published over the last 20 years have
identified viruses (excluding measles) in 8.4% [25] to
45% [26] of LRTI episodes. One of the larger studies,
which included nearly 1,500 Pakistani children <5 years
of age, detected a virus (including adenovirus) in 37% of
cases using viral culture and immunofluorescence (IF)
[27]. Previous community-based studies with longitudi-BMC Medicine 2009, 7:35 http://www.biomedcentral.com/1741-7015/7/35
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nal follow-up of children have identified viruses in 11%
to 45% of LRTI cases [1,28,29].
Not unexpectedly, RSV was by far the most common virus
in our study, identified in 15.1% of all pneumonia cases
and 37.7% of viral positive cases. Etiology studies in
developing countries that included viruses have identified
RSV in a median of 20% (5th to 95th percentile 1 to 53)
of LRTI cases [30] and in 6% to 96% (mean 39%) of LRTI
cases with a viral etiology [1]. It should be noted that
many of these studies also included measles. A recently
published denominator-based study from a birth cohort
comprising 635 Kenyan children followed through three
RSV epidemics reported that 13% of cases with LRTI were
attributable to RSV infection, which was diagnosed using
IF [31]. In India, RSV accounted for 17% of hospitalized
cases with LRTI in New Delhi [32] and 7% of LRTI cases
included in a 3-year longitudinal community study in
Haryana [28]. After RSV, InfA and PIV3 were the most
common viruses in our study, as reported elsewhere
[1,3,28]. We detected hMPV in 4.2% of pneumonia cases.
It is estimated that MPV worldwide accounts for 5 to 7%
Table 1: Background and clinical characteristics of 2,219 cases of community-acquired pneumonia diagnosed over a 3-year period in 
Bhaktapur, Nepal
Characteristic n Value
Demographic
Age in months 2,219
Mean (SD) 13.4 (8.3)
2 to 11 months (%) 1,016 (45.8)
12 to 35 months (%) 1,203 (54.2)
Breastfeeding (%) 2,218 1,945 (87.7)
Boys (%) 2,219 1,263 (56.9)
Mean birth weight in grams (SD)a 1,585 2,856 (464)
Hospital delivery (%) 2,216 1,718 (77.5)
Illiterate (%)b
Mother 2,212 578 (26.1)
Father 2,209 116 (5.3)
Father's occupation (%) 2,216
Agriculture 240 (10.8)
Daily wage earner 1,078 (48.6)
No work 43 (1.9)
Mother's occupation (%) 2,216
Agriculture 222 (10.0)
Daily wage earner 361 (16.3)
No work outside home 1,472 (66.4)
Symptoms and signs at presentation
Median number of days with cough at presentation (IQR) 2,219 3 (2 to 4)
Runny nose according to caregiver (%) 1,882 1,632 (86.7)
Mean respiratory rate in breaths/min (SD)
2 to 11 months 1,016 58 (5.4)
12 to 35 months 1,203 49 (6.5)
Axillary temperature (%) 2,218
≥ 37.5°C 908 (40.9)
≥ 38.5°C 293 (13.2)
Wheezing (%)c 2,219 994 (44.8)
Crepitations (%) 2,219 651 (29.3)
Lower chest indrawing (%) 2,219 131 (5.9)
Oxygen saturation (%) 2,219
<93% 670 (30.2)
<90% 42 (1.9)
Median CRP in mg/L (IQR) 2,215 15 (<8, 28)
Mean hemoglobin in g/dl (SD) 2,218 11.1 (1.2)
Anthropometric
Mean weight for length Z-score (SD) 2,212 -0.26 (1.0)
Mean length for age Z-score (SD) -1.1 (1.2)
Length for age <-2Z-scores (stunted) (%)d 526 (23.8)
Weight for length <-2Z-scores (wasted) (%)d 82 (3.7)
aWritten documentation from 1,273 birth certificates, remaining 312 from mother's recall;bdefined as no schooling/not able to read and 
write;cwheezing prior to administration of nebulized salbutamol; dthe WHO Child Growth Standards 2006 [23].
CRP = C-reactive protein; IQR = inter-quartile range; SD = standard deviation.BMC Medicine 2009, 7:35 http://www.biomedcentral.com/1741-7015/7/35
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of ARI in young children requiring hospitalization [33]. In
India, hMPV was detected in 3.2% of 662 children hospi-
talized for ARI over a 2-year period from April 2005 [34].
RSV and influenza virus are known to occur in well-
defined recurrent epidemics during the cold season in
temperate climates [1,2]. In tropical and subtropical areas,
RSV infections have been reported to peak more often in
relation to the wet season, but locations close to the equa-
tor show a less consistent pattern, some with almost con-
tinuous RSV activity and varying seasonal peaks [1,7].
Studies in the Indian subcontinent have reported RSV
infections to peak both in the cold season [27] and in the
rainy season [35,36], as well as being detectable through-
out the year [35,37]. We observed RSV epidemics both in
winter and during the monsoon. The virus was isolated
during a period of 6 to 7 months and the epidemic peaks
were observed with intervals of 15 and 9 months, which
is consistent with patterns described elsewhere [31,38].
We detected influenza in 25 of the 36 study months. The
largest influenza peaks occurred in winter from December
to February in the first two years, but we also isolated
influenza during the monsoon period. A summer out-
break of influenza has previously been reported from
Nepal [39]. Surveillance data from 2007 at the Kath-
mandu sentinel site has showed that InfB was prevalent
throughout the year except in May, and that InfA prevailed
during June to August and reappeared in December [40].
Unlike in temperate regions, where influenza occurs in
well-defined outbreaks lasting 2 to 3 months once a year
in the winter, influenza is detectable for a greater part of
the year in tropical and sub-tropical regions and the tim-
ing of outbreaks is less predictable [41,42]. Influenza
peaks have been reported to occur during periods of high
rainfall in many tropical locations [12].
We observed one distinct hMPV epidemic, which peaked
between December 2004 and January 2005. The epidemic
lasted from July 2004 to January 2005 and comprised
70% of the hMPV isolates detected during the entire 3-
year study period. Substantial variation in the yearly inci-
dence of hMPV has also been reported earlier [43,44]. Epi-
demics with this virus have been reported to occur during
late winter to spring in temperate climates [33,45], includ-
ing North India [46], where the majority of hMPV were
detected from December to February, and Korea [45],
where hMPV peaked between February and April. A study
in subtropical Hong Kong found hMPV infections mainly
in the spring and summer months [47], similar to that of
RSV [48] and occasionally influenza [49].
We isolated PIV3 in 27 months of our 36 month-study,
but an increasing number of infections were seen between
April to May and September each year, while the largest
epidemic occurred in June 2006. The virus has been
known to exhibit an endemic pattern and to cause yearly
epidemics in spring and summer in temperate climates
[50]. PIV1 was isolated in smaller numbers throughout
the study period (in 28 of 36 months), and we could not
observe the biennial pattern of fall epidemics seen else-
where [51].
As could be observed from the displays of the occurrence
of viral CAPs in the study children [24], the spatial-tempo-
ral distribution of these infections revealed more or less
overlapping micro-epidemics with several respiratory
viral pathogens spreading between households in Bhakta-
pur.
Despite two of the three RSV epidemics occurring during
the summer monsoon, neither rainfall nor temperature
was significantly associated with RSV infections in our
study, while there was a positive correlation with relative
humidity. In tropical Asian countries, somewhat contra-
dictory patterns of associations between RSV and meteor-
ological factors have been observed. In Hong Kong, the
monthly incidence of RSV infection was positively corre-
lated with both temperature and relative humidity [48],
whereas in Malaysia, the number of RSV infections was
Table 2: Distribution of the different RNA viruses in 2,219 cases of community-acquired pneumonia in children 2 to 35 months of age 
diagnosed at a field clinic in Bhaktapur, Nepal, from July 2004 to June 2007
Number of isolates All pneumonia cases Virus positive cases
(n = 2,219) (n = 887)
Virus n % (95% CI) % (95% CI)
RSV 334 15.1 (13.6 to 16.6) 37.7 (34.5 to 40.9)
Influenza A 164 7.4 (6.3 to 8.6) 18.5 (16.0 to 21.2)
PIV type 3 129 5.8 (4.9 to 6.9) 14.5 (12.3 to 17.0)
PIV type 1 98 4.4 (3.6 to 5.4) 11.0 (9.1 to 13.3)
hMPV 93 4.2 (3.4 to 5.1) 10.5 (8.5 to 12.7)
Influenza B 84 3.8 (3.0 to 4.7) 9.5 (7.6 to 11.6)
PIV type 2 17 0.8 (0.4 to 1.2) 1.9 (1.1 to 3.1)
CI = confidence interval; hMPV = human metapneumovirus; PIV = parainfluenza virus; RSV = respiratory syncytial virus.BMC Medicine 2009, 7:35 http://www.biomedcentral.com/1741-7015/7/35
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inversely correlated with temperature [52]. RSV infections
peaked towards the end of the rainy season during the first
and third year of our study. We explored whether there
could be an association between preceding rainfall and
RSV infections, and by introducing a 2-month lag after
peak precipitation, such an association could indeed be
identified (data not shown).
A strong association with relative humidity was also
found for hMPV infections. Association with meteorolog-
ical factors has not previously been described for this
virus. Belonging to the Pneumovirinae  subfamily [53],
both RSV and hMPV could require similar conditions for
transmission and infectivity. In contrast, PIV3 was
strongly and positively correlated with both temperature
and rainfall, but not with relative humidity. A study in
Singapore found no such associations for PIV3 [54]. It is
also interesting to note that, in our study, InfB infections
showed an inverse correlation with relative humidity,
temperature and rainfall, while InfA infections did not
correlate with any of these meteorological factors. In Sin-
gapore, InfA outbreaks were also not associated with
meteorological factors, but InfB infections were reported
to positively correlate with rainfall [54].
As derived from the correlation analyses (rs = 0.68), up to
46% of the monthly variation in occurrence of viral infec-
tions in our study could be explained by meteorological
factors. However, the underlying reasons for the observed
seasonal patterns demonstrated by these individual respi-
ratory viruses are unclear. Climate could have a direct
impact on virus survival, transmission efficiency, and host
immunity, or have an indirect effect through climate-
dependent behavior change, such as indoor crowding and
eating habits [55]. It is likely that several factors interact in
complex ways in the development of observed epidemics
under favorable climatic conditions and that the contribu-
tion of individual factors varies for the different viruses.
Monthly number of community-acquired pneumonia cases  and cases with a positive virus PCR in children aged 2 to 35  months identified at a field clinic in Bhaktapur, Nepal, from  July 2004 to June 2007 Figure 2
Monthly number of community-acquired pneumonia 
cases and cases with a positive virus PCR in children 
aged 2 to 35 months identified at a field clinic in 
Bhaktapur, Nepal, from July 2004 to June 2007.
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Monthly number of viral isolates in nasopharyngeal speci- mens from 2,219 cases with community-acquired pneumonia  in children 2 to 35 months of age identified at a field clinic in  Bhaktapur, Nepal, from July 2004 to June 2007 Figure 3
Monthly number of viral isolates in nasopharyngeal 
specimens from 2,219 cases with community-
acquired pneumonia in children 2 to 35 months of 
age identified at a field clinic in Bhaktapur, Nepal, 
from July 2004 to June 2007. Parainfluenza 2 isolates 
were not included in the graph due to few positive cases.
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We detected more than one virus in 3.3% of the virus-pos-
itive NPA specimens, which is similar to what is reported
using molecular methods detecting the same viruses as in
our study [56], but lower compared with studies using
molecular methods detecting a wider array of viruses
[57,58]. The frequency of viral co-detections varies widely
and depends on the number of diagnostic methods
applied [59] and the number of pathogens tested for [58].
By employing multiplex PCR assays for 11 viruses, a study
in 515 Korean children aged ≤ 5 years detected viruses in
312 (60.6%) of cases and a viral co-detection in 36
(11.5%) [45]. In addition to the seven viruses identified in
our study, the Korean study also detected adenovirus,
coronavirus, rhinovirus, and bocavirus; and, notably, the
last virus was identified in 22 of the 36 co-detections. The
clinical role of bocavirus in pneumonia in otherwise
healthy children is unclear [60,61], as is the importance of
multiple viral infections [57,59]. Quantitative PCR meth-
ods to determine viral load in clinical specimens could
provide valuable information on the pathogenetic role of
each virus in such co-detections [61], as could case-con-
trol studies.
Compared with pneumonia, pulmonary tuberculosis is
not common in young Nepalese children [62]. To avoid
including cases of undiagnosed tuberculosis and reactive
airway disease, we did not include children that had been
coughing for more than 14 days and we reassessed respi-
ratory rate in wheezers after salbutamol administration
before diagnosis of pneumonia [20]. The number of mea-
sles cases in Nepal has decreased dramatically since 2003
[63]. Measles vaccination is recommended at 9 months
and the vaccine coverage among those that were 9 months
or older in our study area was >90% (unpublished data).
Moreover, less than 1% of our cases had a rash and all of
these were above 1 year of age. Thus, we believe that our
sample consisted of children with pneumonia, and not
tuberculosis, bronchial asthma, or measles.
Despite the high sensitivity and specificity of the Hexaplex
Plus assay [15], we may have underestimated the number
of viral infections. Viral load in a specimen depends on
several conditions, such as time of collection in relation to
onset of illness. In most of the study children, the NPA
specimen was collected early in the course of illness,
which increases the likelihood of detecting an infectious
agent [14]. Moreover, by not including children who had
taken antibiotics during the last 48 hours, we primarily
recruited new cases of pneumonia. Using multiplex
instead of single molecular assays may have contributed
to an underestimation of the number of viral CAP cases,
as some loss of sensitivity is an inherent limitation of mul-
tiplex PCR assays [13].
We observed a large month-to-month variation in the
proportion of CAP cases from whom we identified a res-
Table 3: Spearman's correlation coefficients for association between monthly number of different viral infections and meteorological 
factors
Virus Relative humidity (%)a Temperature (°C)a Rainfall (mm)b
RSV 0.40 (P = 0.015) -0.058 (P = 0.74) -0.061 (P = 0.72)
Influenza A 0.023 (P = 0.89) -0.034 (P = 0.084) -0.12 (P = 0.47)
PIV type 3 -0.088 (P = 0.61) 0.65 (P <0.0001) 0.68 (P <0.0001)
PIV type 1 -0.38 (P = 0.024) 0.17 (P = 0.31) 0.23 (P = 0.18)
Influenza B -0.34 (P = 0.045) -0.31 (P = 0.066) -0.39 (P = 0.019)
hMPV 0.55 (P = 0.0005) -0.15 (P = 0.37) 0.022 (P = 0.90)
PIV type 2 0.15 (P = 0.39) 0.39 (P = 0.019) 0.30 (P = 0.078)
aMean daily measurement for the month; btotal measurement for the month.
hMPV = human metapneumovirus; PIV = parainfluenza virus; RSV = respiratory syncytial virus.
Monthly number of RSV infections in children aged 2 to 35  months with community-acquired pneumonia from 29 June  2004 to 30 June 2007, in Bhaktapur, Nepal, depicted with  monthly variation of relative humidity, rainfall and tempera- ture Figure 4
Monthly number of RSV infections in children aged 2 
to 35 months with community-acquired pneumonia 
from 29 June 2004 to 30 June 2007, in Bhaktapur, 
Nepal, depicted with monthly variation of relative 
humidity, rainfall and temperature. The mean daily 
measurement for the month was used for relative humidity 
and temperature, while rainfall was calculated as the total 
measurement for the month.
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piratory RNA virus, largely reflecting the epidemic pattern
of viral infections in this sub-tropical setting. A limitation
of our study was that we were not able to include more eti-
ologic agents in our diagnostic panel. Adenovirus is
among the more common viral respiratory pathogens
causing LRTI in preschool children [64]. Atypical bacteria,
like Mycoplasma pneumoniae, cause pneumonia more fre-
quently in school-age children, but can also cause mild
infections in younger children [65]. Streptococcus pneumo-
niae  and  Haemophilus influenza are the main bacterial
pathogens causing childhood pneumonia. However,
nasopharyngeal carriage of these bacteria is frequent in
healthy, young children [66]. Moreover, their detection in
pneumonia is hampered by the difficulties of obtaining
specimens from the lower airways and the low sensitivity
of identifying these pathogens by blood culture [67], and
such invasive methods are not well suited for community
settings. S. pneumoniae has been suggested to play a role in
the development of virus-associated pneumonia in chil-
dren in hospital, especially in cases with influenza and
PIV types 1 to 3 [68]. The monthly number of cases where
we did not identify any virus was particularly pronounced
in the CAP epidemic that peaked in December 2005 (Fig-
ure 2), which comprised the largest outbreaks of influenza
A and B (Figure 3). There is abundant evidence that infec-
tion with influenza viruses predisposes for pneumococcal
disease [69]. Additionally, we cannot rule out the possi-
bility that some of the cases where we detected a viral
pathogen in fact had a mixed viral-bacterial pneumonia or
pneumonia after acquisition of a new pneumococcal sero-
type during an upper respiratory viral infection. Again,
quantitative PCR methods and carefully conducted case-
control studies could shed light on the clinical importance
of detecting viral pathogens in NPA specimens from chil-
dren with pneumonia.
Conclusion
We detected a viral pathogen from the nasopharynx in
40% of the children with CAP in this study, indicating
that respiratory RNA viruses play an important role in this
common childhood illness in Nepal. RSV was the most
common agent isolated, and occurred with considerable
temporal variation. As for many other common child-
hood infections, such as diarrhea, the occurrence of viral
CAP in this community seemed to reflect more or less
overlapping micro-epidemics with several respiratory
viruses, highlighting the challenges of developing and
implementing effective public health control measures in
resource-poor settings.
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